Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma
- Author
- MITCHELL, Malcolm S; ABRAMS, Judith; JAKOWATZ, James G; DAS GUPTA, Tapas K; RICHARDS, Jon M; SAMLOWSKI, Wolfram E; COSTANZI, John J; ARONSON, Frederick R; DEISSEROTH, Albert B; DUDEK, Arkadiusz Z; JONES, Vicky E; THOMPSON, John A; KASHANI-SABET, Mohammed; DECONTI, Ronald C; HWU, Wen-Jen; ATKINS, Michael B; WHITMAN, Eric; ERNSTOFF, Marc S; HALUSKA, Frank G
[1] University of California, San Diego, School of Medicine and Cancer Center, San Diego, United States
[2] University of California, San Francisco, United States
[3] School of Medicine and Cancer Center, San Francisco, United States
[4] University of California, Irvine Medical School and Cancer Center, Irvine, CA, United States
[5] Karmanos Cancer Institute, Wayne State University, Detroit, United States
[6] Van Elslander Cancer Center, St John Medical Center, Grosse Pointe Woods, MI, United States
[7] University of Washington School of Medicine, Seattle, WA, United States
[8] Moffitt Cancer Center, University of South Florida, Tampa, FL, United States
[9] Yale Comprehensive Cancer Center, New Haven, CT, United States
[10] Beth Israel Medical Center, Harvard Medical School, Massachusetts, United States
[11] General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States
[12] The Melanoma Center of St. Louis, St Louis, MO, France
[13] Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Hanover, NH, United States
[14] University of Illinois at Chicago, Chicago, United States
[15] Oncology Specialists, Park Ridge, IL, United States
[16] Huntsman Cancer Center, University of Utah, Salt Lake City, UT, United States
[17] Lone Star Oncology, Austin, TX, United States
[18] Maine Center for Cancer Medicine, Scarborough, ME, Canada
[19] University of Minnesota, Minneapolis, MN, United States
[20] Karmanos Cancer Institute, United States - Source
Journal of clinical oncology. 2007, Vol 25, Num 15, pp 2078-2085, 8 p ; ref : 28 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cancérologie Dose faible Dose forte Essai clinique Etude comparative Interféron alpha Lysat Mélanome malin Randomisation Stade avancé Vaccin Cancer de la peau Interféron alfa Peau pathologie Tumeur maligne
- Keyword (en)
- Cancerology Low dose High dose Clinical trial Comparative study Alpha interferon Lysate Malignant melanoma Randomization Advanced stage Vaccine Skin cancer Interferon alfa Skin disease Malignant tumor
- Keyword (es)
- Cancerología Dosis débil Dosis fuerte Ensayo clínico Estudio comparativo Interferón alfa Lisado Melanoma maligno Aleatorización Estadio avanzado Vacuna Cáncer de piel Interferón alfa Piel patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08A Tumors of the skin and soft tissue. Premalignant lesions
- Discipline
- Dermatology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18790717
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2006.10.1709 
https://dx.doi.org/10.1200/JCO.2006.10.1709
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.10.1709\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"2078\";s:8:\"\u0000*\u0000epage\";s:4:\"2085\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MITCHELL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Malcolm S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:14:\"ABRAMS, Judith\";i:1;s:17:\"JAKOWATZ, James G\";i:2;s:18:\"DAS GUPTA, Tapas K\";i:3;s:15:\"RICHARDS, Jon M\";i:4;s:20:\"SAMLOWSKI, Wolfram E\";i:5;s:16:\"COSTANZI, John J\";i:6;s:20:\"ARONSON, Frederick R\";i:7;s:20:\"DEISSEROTH, Albert B\";i:8;s:18:\"DUDEK, Arkadiusz Z\";i:9;s:14:\"JONES, Vicky E\";i:10;s:16:\"THOMPSON, John A\";i:11;s:23:\"KASHANI-SABET, Mohammed\";i:12;s:17:\"DECONTI, Ronald C\";i:13;s:12:\"HWU, Wen-Jen\";i:14;s:17:\"ATKINS, Michael B\";i:15;s:13:\"WHITMAN, Eric\";i:16;s:16:\"ERNSTOFF, Marc S\";i:17;s:16:\"HALUSKA, Frank G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.10.1709\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"2078\";s:8:\"\u0000*\u0000epage\";s:4:\"2085\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MITCHELL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Malcolm S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:14:\"ABRAMS, Judith\";i:1;s:17:\"JAKOWATZ, James G\";i:2;s:18:\"DAS GUPTA, Tapas K\";i:3;s:15:\"RICHARDS, Jon M\";i:4;s:20:\"SAMLOWSKI, Wolfram E\";i:5;s:16:\"COSTANZI, John J\";i:6;s:20:\"ARONSON, Frederick R\";i:7;s:20:\"DEISSEROTH, Albert B\";i:8;s:18:\"DUDEK, Arkadiusz Z\";i:9;s:14:\"JONES, Vicky E\";i:10;s:16:\"THOMPSON, John A\";i:11;s:23:\"KASHANI-SABET, Mohammed\";i:12;s:17:\"DECONTI, Ronald C\";i:13;s:12:\"HWU, Wen-Jen\";i:14;s:17:\"ATKINS, Michael B\";i:15;s:13:\"WHITMAN, Eric\";i:16;s:16:\"ERNSTOFF, Marc S\";i:17;s:16:\"HALUSKA, Frank G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.10.1709\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.10.1709\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"2078\";s:8:\"\u0000*\u0000epage\";s:4:\"2085\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MITCHELL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Malcolm S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:14:\"ABRAMS, Judith\";i:1;s:17:\"JAKOWATZ, James G\";i:2;s:18:\"DAS GUPTA, Tapas K\";i:3;s:15:\"RICHARDS, Jon M\";i:4;s:20:\"SAMLOWSKI, Wolfram E\";i:5;s:16:\"COSTANZI, John J\";i:6;s:20:\"ARONSON, Frederick R\";i:7;s:20:\"DEISSEROTH, Albert B\";i:8;s:18:\"DUDEK, Arkadiusz Z\";i:9;s:14:\"JONES, Vicky E\";i:10;s:16:\"THOMPSON, John A\";i:11;s:23:\"KASHANI-SABET, Mohammed\";i:12;s:17:\"DECONTI, Ronald C\";i:13;s:12:\"HWU, Wen-Jen\";i:14;s:17:\"ATKINS, Michael B\";i:15;s:13:\"WHITMAN, Eric\";i:16;s:16:\"ERNSTOFF, Marc S\";i:17;s:16:\"HALUSKA, Frank G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.10.1709\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"2078\";s:8:\"\u0000*\u0000epage\";s:4:\"2085\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MITCHELL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Malcolm S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:14:\"ABRAMS, Judith\";i:1;s:17:\"JAKOWATZ, James G\";i:2;s:18:\"DAS GUPTA, Tapas K\";i:3;s:15:\"RICHARDS, Jon M\";i:4;s:20:\"SAMLOWSKI, Wolfram E\";i:5;s:16:\"COSTANZI, John J\";i:6;s:20:\"ARONSON, Frederick R\";i:7;s:20:\"DEISSEROTH, Albert B\";i:8;s:18:\"DUDEK, Arkadiusz Z\";i:9;s:14:\"JONES, Vicky E\";i:10;s:16:\"THOMPSON, John A\";i:11;s:23:\"KASHANI-SABET, Mohammed\";i:12;s:17:\"DECONTI, Ronald C\";i:13;s:12:\"HWU, Wen-Jen\";i:14;s:17:\"ATKINS, Michael B\";i:15;s:13:\"WHITMAN, Eric\";i:16;s:16:\"ERNSTOFF, Marc S\";i:17;s:16:\"HALUSKA, Frank G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2006.10.1709\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"2078\";s:8:\"\u0000*\u0000epage\";s:4:\"2085\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MITCHELL\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Malcolm S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:14:\"ABRAMS, Judith\";i:1;s:17:\"JAKOWATZ, James G\";i:2;s:18:\"DAS GUPTA, Tapas K\";i:3;s:15:\"RICHARDS, Jon M\";i:4;s:20:\"SAMLOWSKI, Wolfram E\";i:5;s:16:\"COSTANZI, John J\";i:6;s:20:\"ARONSON, Frederick R\";i:7;s:20:\"DEISSEROTH, Albert B\";i:8;s:18:\"DUDEK, Arkadiusz Z\";i:9;s:14:\"JONES, Vicky E\";i:10;s:16:\"THOMPSON, John A\";i:11;s:23:\"KASHANI-SABET, Mohammed\";i:12;s:17:\"DECONTI, Ronald C\";i:13;s:12:\"HWU, Wen-Jen\";i:14;s:17:\"ATKINS, Michael B\";i:15;s:13:\"WHITMAN, Eric\";i:16;s:16:\"ERNSTOFF, Marc S\";i:17;s:16:\"HALUSKA, Frank G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
